偽膜性大腸炎
□記事を途中から表示しています
[最初から表示]
^ 話題の感染症 ディフィシル菌感染症の基礎と臨床 モダンメディア 2010年10月号（第56巻10号） (PDF)
^ Curry J (2007年7月20日). “ ⇒Pseudomembranous Colitis”. WebMD. 2008年11月17日閲覧。
^ a b c d e f g h Ryan KJ, Ray CG (editors) (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. pp. 322?4. ISBN 0-8385-8529-9
^ a b Lessa, Fernanda C.; Mu, Yi; Bamberg, Wendy M.; Beldavs, Zintars G.; Dumyati, Ghinwa K.; Dunn, John R.; Farley, Monica M.; Holzbauer, Stacy M. et al. (26 February 2015). “Burden of Infection in the United States”. New England Journal of Medicine 372 (9): 825?834. doi:10.1056/NEJMoa1408913.
^ Liddell-Scott. “κλωστ?ρ”. Greek-English Lexicon (Oxford){{inconsistent citations}}
^ Cawley, Kevin. ⇒“Difficilis”. Latin Dictionary and Grammar Aid (University of Notre Dame). ⇒http://www.archives.nd.edu/cgi-bin/lookup.pl?stem=Difficilis&ending= 2013年3月16日閲覧。{{inconsistent citations}}
^ 國島広之「 ⇒Clostridium difficile」『臨床検査』第58巻第7号、2008年7月15日、722-3頁、doi:10.11477/mf.1542101657、ISSN 0485-1420、2016年7月7日閲覧。
^ a b c d e 岡健太郎、高橋志達、神谷茂、Clostridium difficile腸炎とプロバイオティクス 腸内細菌学雑誌 29巻 (2015) 4号 p.177-185, doi:10.11209/jim.29.177
^ “Inpatient diarrhoea and Clostridium difficile infection”. Clinical Medicine 12 (6): 583?588. (2012). doi:10.7861/clinmedicine.12-6-583.
^ Bomers, Marije (April 2015). “Rapid, Accurate, and On-Site Detection of C. difficile in Stool Samples”. The American Journal of Gastroenterology 110 (4): 588?594. doi:10.1038/ajg.2015.90. PMID 25823766.
^ “Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea”. The American Journal of Medicine 100 (5): 487?95. (May 1996). doi:10.1016/S0002-9343(95)00016-X. PMID 8644759.
^ Di Bella, Stefano; Ascenzi, Paolo; Siarakas, Steven; Petrosillo, Nicola; di Masi, Alessandra (2016-01-01). ⇒“Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects”. Toxins 8 (5). doi:10.3390/toxins8050134. ISSN 2072-6651. PMC 4885049. PMID 27153087. ⇒http://www.ncbi.nlm.nih.gov/pubmed/27153087.
^ “The low molecular mass GTP-binding protein Rh is affected by toxin a from Clostridium difficile”. The Journal of Clinical Investigation 95 (3): 1026?31. (1995). doi:10.1172/JCI117747. PMC 441436. PMID 7883950. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC441436/.
^ “Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins”. Microbiology and Molecular Biology Reviews : MMBR 68 (3): 373?402, table of contents. (2004). doi:10.1128/MMBR.68.3.373-402.2004. PMC 515256. PMID 15353562. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC515256/.
^ “A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality”. The New England Journal of Medicine 353 (23): 2442?9. (December 2005). doi:10.1056/NEJMoa051639. PMID 16322602.
^ McDonald LC (August 2005). “Clostridium difficile: responding to a new threat from an old enemy”. Infection Control and Hospital Epidemiology 26 (8): 672?5. doi:10.1086/502600. PMID 16156321. http://www.cdc.gov/ncidod/dhqp/pdf/infDis/Cdiff_ICHE08_05.pdf.
^ 山根誠久、仲宗根勇、「グラム陰性球菌、グラム陽性桿菌 病院感染を起こす代表的な微生物（感染経路と病原性）」 『環境感染』 2000年 15巻 Supplement号 p.33-36, doi:10.11550/jsei1986.15.Supplement_33
^ “Clostridium difficile infection: New developments in epidemiology and pathogenesis”. Nature Reviews. Microbiology 7 (7): 526?36. (July 2009). doi:10.1038/nrmicro2164. PMID 19528959.
^ Luciano, JA; Zuckerbraun, BS (December 2014). “Clostridium difficile infection: prevention, treatment, and surgical management”. The Surgical clinics of North America 94 (6): 1335?49. doi:10.1016/j.suc.2014.08.006. PMID 25440127.
^ “Scientists probe whether C. difficile is linked to eating meat”. CBC News. (2006年10月4日). ⇒オリジナルの2006年10月24日時点におけるアーカイブ。. https://web.archive.org/web/20061024034645/http://www.cbc.ca:80/health/story/2006/10/04/cdifficile-meat.html
^ “Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection”. The Journal of Infectious Diseases 166 (3): 561?7. (September 1992). doi:10.1093/infdis/166.3.561. PMID 1323621.
^ Halsey J (2008). “Current and future treatment modalities for Clostridium difficile-associated disease”. American Journal of Health-System Pharmacy 65 (8): 705?15. doi:10.2146/ajhp070077. PMID 18387898.
^ “Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection”. Archives of Internal Medicine 170 (9): 784?90. (May 2010). doi:10.1001/archinternmed.2010.89. PMID 20458086.
^ “Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis”. Clinical Gastroenterology and Hepatology 10 (3): 225?33. (March 2012). doi:10.1016/j.cgh.2011.09.030. PMID 22019794.
^ Sarah A. Kuehne; Stephen T. Cartman; John T. Heap; Michelle L. Kelly; Alan Cockayne; Nigel P. Minton (2010). “The role of toxin A and toxin B in Clostridium difficile infection”. Nature 467 (7316): 711?3. doi:10.1038/nature09397. PMID 20844489.
^ “ ⇒Surgical Pathology Criteria: Pseudomembranous Colitis”. Stanford School of Medicine. 2016年7月7日閲覧。
^ Manual of Clinical Microbiology (8th ed.). Washington DC: ASM Press. (2003). ISBN 1-55581-255-4 [要ページ番号]
次ページ記事の検索おまかせリスト▼オプションを表示暇つぶしWikipedia
Size:94 KB
出典: フリー百科事典『ウィキペディア（Wikipedia）』
担当:undef